Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 2001

View Archived Issues

NC-381 shows potential inhibitory effects on prostate tumor growth in preclinical studies

Early data from NHL patients treated with CpG-7909 indicate good safety, immunostimulatory effects

Potential of CP-461 in CLL supported by laboratory research discussed at ASH meeting

Valrocemide characterized as a safe, broad-spectrum anticonvulsant agent

Mechanism of anticonvulsant action of CGX-1007, an NMDA antagonist, explored

Retigabine appears not to interfere with low-dose oral contraceptives

Zonegran effective and safe as monotherapy in partial seizures

Repifermin continues to show excellent safety profile in phase II trials for various indications

Amsterdam Molecular Therapeutics receives grant for LPL gene therapy

Excellent safety, evidence of activity for beta-alethine in immunocompetent lymphoma patients

First phase III trial of AC-2993 for type 2 diabetes under way

Synsorb discontinues Synsorb-Cd development program

Initiation of second phase I trial of Triapine in advanced leukemia

Endovasc submits revised phase III protocol for Liprostin; requests FDA meeting

Microbiotix obtains exclusive worldwide license to novel antiviral compounds

Notice of allowance of patent for once-daily Cidecin dosing regimen

Wide series of macrocyclic compounds for HCV designed and disclosed in recent patent

CXCR1/CXCR2 receptor antagonists in the GSK pipeline

Definity launched in North American markets for contrast enhancement in echocardiography

Inhibitors of VEGF receptor tyrosine kinase and their use described by AstraZeneca

New piperidines described in patent literature act as NK1 receptor antagonists

Somatostatin sst2 receptor antagonists synthesized at Pfizer elevate GH secretion

Novartis presents potent new PDE5 inhibitors for erectile dysfunction

Tyrosine kinase inhibitors useful in cancer Rx designed at Boehringer Ingelheim

CPMP recommends approval of Dynepo for anemia of renal failure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...